肝硬化门静脉血栓形成的相关危险因素

doi:10.6040/j.issn.1671-7554.0.2018.183

摘要/Abstract

摘要： 目的探讨肝硬化患者门静脉血栓(PVT)形成的相关危险因素。方法回顾性分析1 670例肝硬化患者病例资料,将其中217例发生PVT者纳入PVT组,随机选择250例未发生PVT者纳入非PVT组。记录两组患者的一般资料、实验室检查结果、临床表现及并发症、手术及药物应用史情况,运用单因素分析和多因素分析方法寻找肝硬化PVT发生的相关危险因素。结果 1 670例肝硬化患者中13%并发PVT,肝功能分级以Child-Pugh B和C级为主。单因素分析显示,两组在D-二聚体、Hb、TBiL、重度食管静脉曲张、脾切除手术、止血药物及心得安使用方面差异均有统计学意义(P<0.05)。多因素非条件Logistic回归分析显示,重度食管静脉曲张(OR=6.918, P=0.018)、脾切除手术(OR=4.281, P=0.007)、D-二聚体升高(OR=5.007, P<0.001)为肝硬化PVT形成的独立危险因素。结论止血药物、心得安、D-二聚体升高、重度食管静脉曲张、脾切除术均可能与肝硬化PVT的形成有关,其中重度食管静脉曲张、脾切除术、D-二聚体升高为肝硬化PVT形成的独立危险因素。

关键词: 肝硬化, 静脉血栓形成, 门静脉, 危险因素

Abstract: Objective To investigate the risk factors of portal vein thrombosis(PVT)in cirrhotic patients. Methods The clinical data of 1 670 hospitalized cirrhotic patients were retrospectively analyzed, of whom 217 with PVT were classified into the PVT group, while 250 without PVT were randomized into the non-PVT group. The general information, laboratory results, clinical manifestations, complications, surgery and drug administration history of the two groups were recorded. The risk factors of PTV were analyzed with univariate analysis and multivariate Logistic regression analysis. Results Of the 1 670 cirrhotic patients, 13% developed PVT, whose liver function was classified as Child-Pugh B and C. Univariate analysis showed significant differences in d-dimer, hemoglobin(Hb), total bilirubin(TBiL), severe esophageal varices, previous splenectomy, hemostatic drugs and propranolol between the two groups. Multivariate Logistic regression analysis showed that severe esophageal varices(OR=6.918, P=0.018), previous splenectomy(OR=4.281, P=0.007)and increase of d-dimer(OR=5.007, P<0.001)were independent risk factors of PVT. Conclusion Hemostatic drugs, propranolol, increase of d-dimer, severe esophageal varices, previous splenectomy may be associated with the formation of PVT in cirrhotic patients. Severe esophageal varices, previous splenectomy and increase of d-dimer are independent risk factors of PVT.

Key words: Liver cirrhosis, Venous thrombosis, Portal vein, Risk factors

中图分类号:

R575.2

丁艳菲,杨卓鑫,郑文文,袁文杰,高艳景. 肝硬化门静脉血栓形成的相关危险因素[J]. 山东大学学报 (医学版), 2018, 56(12): 13-18.

DING Yanfei, YANG Zhuoxin, ZHENG Wenwen, YUAN Wenjie, GAO Yanjing. Risk factors of portal vein thrombosis in patients with liver cirrhosis[J]. Journal of Shandong University (Health Sciences), 2018, 56(12): 13-18.

参考文献

[1] Shah SL, Anderson JC, Shatzel JJ, et al. The epidemiology and clinical associations of portal vein thrombosis in hospitalized patients with cirrhosis: a nationwide analysis from the national inpatient sample[J]. J Hosp Med, 2018, 13(5):324-325.
[2] Qi X, Han G, Fan D. Management of portal vein thrombosis in liver cirrhosis[J]. Nat Rev Gastroenterol Hepatol, 2014, 11(7): 435-446.
[3] 臧立娜, 孙自勤, 刘文波, 等. 食管胃静脉曲张经内镜治疗后再出血危险因素的Meta分析[J]. 中华肝脏病杂志, 2015, 23(4): 275-280. ZANG Lina, SUN Ziqin, LIU Wenbo, et al. Meta-analysis of risk factors of gastroesophageal varices rebleeding after therapeutic endoscopy[J]. Chinese Journal of Hepatology, 2015, 23(4): 275-280.
[4] Dell'era A, Iannuzzi F, Fabris FM, et al. Impact of portal vein thrombosis on the efficacy of endoscopic variceal band ligation[J]. Dig Liver Dis, 2014, 46(2): 152-156.
[5] Qi X, Dai J, Yang M, et al. Association between portal vein thrombosis and survival in non-liver-transplant patients with liver cirrhosis: a systematic review of the literature[J]. Gastroenterol Res Pract, 2015, 2015: 480842. doi:10.1155/2015/480842.
[6] Bagheri Lankarani K, Homayon K, Motevalli D, et al. Risk factors for portal vein thrombosis in patients with cirrhosis awaiting liver transplantation in shiraz, iran[J]. Hepat Mon, 2015, 15(12): e26407. doi:10.5812/hepatmon.26407.
[7] Ghabril M, Agarwal S, Lacerda M, et al. Portal vein thrombosis is a risk factor for poor early outcomes after liver transplantation: analysis of risk factors and outcomes for portal vein thrombosis in waitlisted patients[J]. Transplantation, 2016, 100(1): 126-133.
[8] Nery F, Chevret S, Condat B, et al. Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study[J]. Hepatology, 2015, 61(2): 660-667.
[9] Kinjo N, Kawanaka H, Akahoshi T, et al. Portal vein thrombosis in liver cirrhosis[J]. World J Hepatol, 2014, 6(2): 64-71.
[10] Abdel-Razik A, Mousa N, Elhelaly R, et al. De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the Model for End-stage Liver Disease scoring system[J]. Eur J Gastroenterol Hepatol, 2015, 27(5): 585-592.
[11] Harding DJ, Perera MT, Chen F, et al. Portal vein thrombosis in cirrhosis: Controversies and latest developments[J]. World J Gastroenterol, 2015, 21(22): 6769-6784.
[12] Francoz C, Valla D, Durand F. Portal vein thrombosis, cirrhosis, and liver transplantation[J]. J Hepatol, 2012, 57(1): 203-212.
[13] Maruyama H, Okugawa H, Takahashi M, et al. De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes[J]. Am J Gastroenterol, 2013, 108(4): 568-574.
[14] Violi F, Corazza GR, Caldwell SH, et al. Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry[J]. Intern Emerg Med, 2016, 11(8): 1059-1066.
[15] Francoz C, Belghiti J, Vilgrain V, et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation[J]. Gut, 2005, 54(5): 691-697.
[16] Morisaka H, Motosugi U, Ichikawa T, et al. MR-based measurements of portal vein flow and liver stiffness for predicting gastroesophageal varices[J]. Magn Reson Med Sci, 2013,12(2): 77-86.
[17] Tarzamni MK, Somi MH, Farhang S, et al. Portal hemodynamics as predictors of high risk esophageal varices in cirrhotic patients[J]. World J Gastroenterol, 2008, 14(12): 1898-1902.
[18] Zocco MA, Di Stasio E, De Cristofaro R, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development[J]. J Hepatol, 2009, 51(4): 682-689.
[19] Ikeda M, Sekimoto M, Takiguchi S, et al. High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan[J]. Ann Surg, 2005, 241(2): 208-216.
[20] Li MX, Zhang XF, Liu ZW, et al. Risk factors and clinical characteristics of portal vein thrombosis after splenectomy in patients with liver cirrhosis[J]. Hepatobiliary Pancreat Dis Int, 2013, 12(5): 512-519.
[21] Matsumoto T, Yamagami T, Terayama K, et al. Risk factors and clinical course of portal and/or splenic vein thrombosis after partial splenic embolization[J]. Acta Radiol, 2009, 50(6): 617-623.
[22] 李征然, 单鸿, 朱康顺, 等. 部分性脾栓塞术改变门脉血流动力学的定量研究[J]. 中华放射学杂志, 2002, 36(10): 913-917. LI Zhengran, SHAN Hong, ZHU Kangshun, et al. Clinical quantitative study of therapeutic effect of partial splenic embolization(PSE)on portal vein hemodynamics[J]. Chinese Journal of Radiology, 2002, 36(10): 913-917.
[23] Pellicelli AM, Ambrosio CD, Barbaro G, et al. Clinical and genetic factors associated to development of portal vein thrombosis in cirrhotic patients without hepatocellular carcinoma[J]. Journal of Hepatology, 2011, 54: S77. doi:10.1016/S0168-8278(11)60182-7.
[24] Zampino R, Lebano R, Coppola N, et al. The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients[J]. Saudi J Gastroenterol, 2018, 24(1): 25-29.
[25] Qi XS, Bai M, Fan DM. Nonselective β-blockers may induce development of portal vein thrombosis in cirrhosis[J]. World J Gastroenterol, 2014, 20(32): 11463-11466.
[26] Dai J, Qi X, Li H, et al. Role of D-dimer in the development of portal vein thrombosis in liver cirrhosis: a meta-analysis[J]. Saudi J Gastroenterol, 2015, 21(3): 165-174.
[27] de Franchis R, Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension[J]. J Hepatol, 2015, 63(3): 743-752.
[28] 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会内镜学分会, 等. 肝硬化门静脉高压食管胃静脉曲张出血防治指南(2015)[J]. 中华胃肠内镜电子杂志, 2015, 2(4): 1-21.

相关文章 15

[1]	王韶卿刘毅慧付婷婷成金勇刘强. 肝癌³¹磷磁共振波谱数据的分类[J]. 山东大学学报(医学版), 2209, 47(6): 42-46.
[2]	姚雪,卢冉冉,孙淑玲,高翠平,肖茹,王书会. 风湿性心脏病患者瓣膜置换术后医院感染风险预测评分模型的构建[J]. 山东大学学报 (医学版), 2022, 60(6): 90-96.
[3]	杨丛品,罗卓野,许秀华,李爱民,郝桂敏. 河北省某医院体检3 512例育龄女性生育选择及压力现状[J]. 山东大学学报 (医学版), 2022, 60(4): 62-67.
[4]	吕岩红,张志勉. 2 809名体检人群中高血压与幽门螺杆菌感染的关联性[J]. 山东大学学报 (医学版), 2022, 60(2): 43-47.
[5]	陈丽宇,肖娟,吕仙忠,段宝敏,洪凡真. 影响孕产妇下肢深静脉血栓预后的危险因素分析[J]. 山东大学学报 (医学版), 2021, 59(7): 38-42.
[6]	司海朋,张文灿,李乐,周鑫. Kümmell's病的危险因素和诊治研究进展[J]. 山东大学学报 (医学版), 2021, 59(6): 25-32.
[7]	王纬,王凤琴,韩艳丽. 腹腔镜下右附件囊肿剥除术后发生心脏骤停1例[J]. 山东大学学报 (医学版), 2021, 59(11): 123-124.
[8]	孙胜房,马会力,贾竹亭,李民涛. 车祸所致880例四肢开放性损伤并发早期感染的危险性因素分析[J]. 山东大学学报 (医学版), 2021, 59(1): 72-77.
[9]	陈擎仪,张烜,王娟,孙继伟,曹丹凤, 曹枫林. 妊娠期女性自杀意念的危险因素及其累积效应[J]. 山东大学学报 (医学版), 2021, 59(1): 91-94.
[10]	余之刚,周飞. 非哺乳期感染性乳腺脓肿诊疗策略[J]. 山东大学学报 (医学版), 2018, 56(9): 1-5.
[11]	王旭,张丹丹,郑兆磊,王珮竹,许勤勤,王显军,丁淑军,李秀君. 威海市发热伴血小板减少综合征与气象因素关系[J]. 山东大学学报 (医学版), 2018, 56(8): 114-120.
[12]	田忠艳,李玉倩,刘晓田,史园园,张海庆,张霞,千新玲,尹磊,赵景志,王重建. PSMD6基因rs831571位点多态性与2型糖尿病易感性的病例对照研究[J]. 山东大学学报 (医学版), 2018, 56(7): 51-56.
[13]	龚淇,刘兆爱,李文晓,费志强. 门静脉、肠系膜上静脉广泛血栓形成1例[J]. 山东大学学报（医学版）, 2017, 55(5): 129-130.
[14]	孙启晶,陈方方,李春晓,张才擎. PNI及HGB评估中晚期非小细胞肺癌患者预后的临床价值[J]. 山东大学学报（医学版）, 2017, 55(4): 55-59.
[15]	杜蘅,袁晓东. 阿尔茨海默病病因及发病机制研究进展[J]. 山东大学学报（医学版）, 2017, 55(10): 21-27.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed